Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Brazil has entered an agreement worth $127m to manufacture a Covid-19 vaccine candidate which was developed by the University of Oxford and licensed to AstraZeneca.
Under the agreement, Brazil will be able to produce up to 100 million doses of the vaccine, with an initial target to manufacture more than 30 million doses in December and January.
The Brazilian government’s public health institute, the Oswaldo Cruz Foundation (Fiocruz), will produce the vaccine candidate.